SMA Research Platform

Evidence graph for Spinal Muscular Atrophy

Biology-first target discovery
Christian Fischer / Bryzant Labs
15,934Targets
453Trials
84Drugs
7Datasets
7,947Sources
226,991Claims
263,546Evidence
58,010Hypotheses
DRUGapprovedsmall molecule

risperidone

Approved indications

schizophreniabipolar-disorder

Related claims (0)

No claims matched “risperidone” in free-text search.

Off-Target Findings (26)

T1: 3T4: 8untiered: 15
TargetRoleTierBoltz-2 iPTMChai-1 iPTMVerdict
PFN2SMAT10.876Primary SMA hit
NCALDSMAT10.863Primary SMA hit
GAP43SMAT10.847Primary SMA hit
SMN1_YGboxOTHERT40.934Low relevance
PLS3_EF4OTHERT40.901Low relevance
KCNA2_poreOTHERT40.860Low relevance
ROCK1_aCOTHERT40.792Low relevance
SSH1_phosphataseOTHERT40.791Low relevance
CHRNG_fetalOTHERT40.774Low relevance
PERP_ECL1OTHERT40.767Low relevance
SCN5A_poreOTHERT40.559Low relevance
RIPK3_kinaseUNCLASSIFIED0.966
MLKL_4HBUNCLASSIFIED0.946
LIMK2_aCOTHER0.917
STMN1SMA0.913
CHRNA1_ECDOTHER0.912
RAPSN_ntermOTHER0.905
DNMT3B_catalyticUNCLASSIFIED0.890
EIF4E_capbindingUNCLASSIFIED0.880
ROCK2_aCOTHER0.878
CFL2SMA0.861
LRP4_propellerOTHER0.853
HSP70_NBDOTHER0.838
S100B_dimerUNCLASSIFIED0.761
AGRN_LG3OTHER0.746
CFL1SMA0.707
Login → Command Center